The development of AI is producing multiple winners and losers among programming languages. The best-known languages in datasets regularly produce better, ...

Rising Oracle Java licensing fees and the massive infrastructure requirements of AI workloads are driving the region’s businesses to migrate to OpenJDK distributions.

Copilot Pro+ and Copilot Enterprise users now can run multiple coding agents directly inside GitHub, GitHub Mobile, and ...

Nearly two-thirds of Java users surveyed rely on Java for developing AI applications, with JavaML, Deep Java Library, and OpenCL being the most-used libraries.

For more information, please visit Beyond the classroom, students have already established and now lead six campus clubs focused on entrepreneurship, competitive programming, open source, cultural ...

From Java and ActiveX to Flash, Houdini, and Direct3D, these 1996 releases shaped how we build apps, sites, and games today.

Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...

Read on for our intrepid engineer’s latest set of predictions for the year(s) to come. As has been the case the last couple of years, we’re once again flip-flopping what might otherwise seemingly be ...

The US government is launching an early career hiring and talent development program to bring more technology and artificial intelligence employees to the public sector, as part of the Trump ...

Developers are navigating confusing gaps between expectation and reality. So are the rest of us. Depending who you ask, AI-powered coding is either giving software developers an unprecedented ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based ...

The CMS Innovation Center has debuted a new model to encourage the use of technology to treat chronic diseases, which could be a boon for health tech companies that have struggled with reimbursement.